Medindia

X

Max Neeman International Expands Its Pharmacy Services Facility In Delhi

Wednesday, December 2, 2009 General News J E 4
Advertisement


RESEARCH TRIANGLE PARK, N.C., Dec. 1 Max Neeman Pharmacy services were initiated in 2001 and have expanded over the years serving the top most pharmaceutical companies globally. The facility which was originally set up in an area of 2000 sq. ft. has now doubled in size. Pharmacy services, as part of the suite of services by Max Neeman, are recognized by the global pharma industry as a valuable offering.

The pharmacy inventory management process is considerably robust with highly secure systems. Product distribution is efficient because of strong relationships with the best drug courier companies.

The facility has been successfully audited by more than forty international and national sponsors to date. The expansion of the facility is driven by Max Neeman International's proliferating client base and has enhanced our capacity in rendering services to several customers.

About Max Neeman International

Max Neeman International is one of the leading and largest CROs in India. Our specialty is that we offer services for the successful conduct of Phase II-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2000 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 22 cities with 5 regional offices. Please contact Donald Swankie, Vice President of Business Development for more information (donald.swankie@neeman-medical.com/ +1.919.424.3345). http://www.neeman-medical.com

SOURCE Max Neeman International
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
OrbusNeich Announces First Patient Enrolled in REM...
S
Today Medtipster Launched a New Program to Drive A...